BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 17934907)

  • 1. The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction.
    Boos CJ; Balakrishnan B; Lip GY
    Ann Med; 2008; 40(1):66-73. PubMed ID: 17934907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
    Lee KW; Blann AD; Lip GY
    Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating endothelial cells in acute ischaemic stroke.
    Nadar SK; Lip GY; Lee KW; Blann AD
    Thromb Haemost; 2005 Oct; 94(4):707-12. PubMed ID: 16270621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.
    Freestone B; Lip GY; Chong AY; Nadar S; Lee KW; Blann AD
    Thromb Haemost; 2005 Oct; 94(4):702-6. PubMed ID: 16270620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
    Makin AJ; Blann AD; Chung NA; Silverman SH; Lip GY
    Eur Heart J; 2004 Mar; 25(5):371-6. PubMed ID: 15033248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of exercise stress testing, diurnal variation and temporal decline on circulating progenitor cells.
    Watson T; Shantsila E; Karthikeyan VJ; Jessani S; Goon PK; Lip GY
    Thromb Haemost; 2010 Feb; 103(2):419-25. PubMed ID: 20126832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction.
    Boos CJ; Balakrishnan B; Jessani S; Blann AD; Lip GY
    Chest; 2007 Dec; 132(6):1920-6. PubMed ID: 18079225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.
    Roldán V; Marín F; García-Herola A; Lip GY
    Thromb Res; 2005; 116(4):321-5. PubMed ID: 16038717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart disease.
    Doshi SN; Moat SJ; Lewis MJ; McDowell IF; Giddings JC; Goodfellow J
    Int J Cardiol; 2004 Apr; 94(2-3):203-7. PubMed ID: 15093982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction.
    Jessani SS; Lane DA; Shantsila E; Watson T; Millane TA; Lip GY
    Ann Med; 2009; 41(8):608-18. PubMed ID: 20021313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
    Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B; Chong AY; Nuttall S; Lip GY
    Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction.
    Freestone B; Chong AY; Blann AD; Lip GY
    Thromb Res; 2006; 118(4):479-85. PubMed ID: 16318868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis.
    Boos CJ; Balakrishnan B; Blann AD; Lip GY
    J Thromb Haemost; 2008 Nov; 6(11):1841-50. PubMed ID: 18761720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
    J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
    Lee KW; Blann AD; Lip GY
    Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
    Nadar SK; Al Yemeni E; Blann AD; Lip GY
    Thromb Res; 2004; 113(2):123-8. PubMed ID: 15115667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.